Synchronicity of P53 Mutation and Multiple High-Risk HPV Genotypes, and the Risk of Cervical Cancer among Women in Osogbo, Nigeria

BackgroundIn low-and middle-income countries, high burden of cervical cancer is associated with human papillomavirus (HPV) due to poor screening and diagnostic methods at early stage. Reports showed that there are discrepancies in data correlating HPV-infection with development of cervical cancer while the functional roles of P53 oncogenic mutation are controversial. Furthermore, the molecular pathogenesis of multiple HPV-genotypes remains an open question. Thus, advancing investigations on HPV-associated cervical abnormalities would add to early diagnostic precision.

MethodsTwo hundred (n=200) cervical samples were collected from apparently healthy, active adult women following an ethical approval. Laboratory analyses were conducted through cytological assessment and histochemistry screening using the Papanicolaou smear. PCR methods were used to characterize HPV-DNA genotypes and P53 gene mutations. Positive cervical dysplasia cases were matched with HPV-DNA, and the HPV-genotypes were used to evaluate the prevalence of various HPV-subtypes and the risk of cervical cancer.

ResultsTwenty-six (n=26) cervical dysplasia and fifty-one (n=51) HPV+ were identified comprising single and multiple genotypes. While nine cases (n=9) showed p53 gene mutation with concurrent multiple high-risk HPV (hrHPV) genotypes, none of the single hrHPV genotypes had p53 mutation. More so, individuals with coexisting p53 mutation and multiple hrHPV-genotypes already manifesting cervical dysplasia were 22.2% of the group, while 77.8% had normal cervical architecture, the fate of whom was unknown during investigation. There was a higher cervical dysplasia among those with HPV oncogenes; there were connections between the HPV positivity with some genotypes (hrHPV16,18,31 and 33, respectively) and p53 mutation.

ConclusionP53 gene mutation was independent of HPV-associated cervical abnormalities in single hrHPV-genotype, though other mechanistic drivers attributed to p53 dysfunction by E6 and E7 remain plausible. On the other hand, infection with multiple hrHPVs showed a concomitant predominance with the P53 mutation, implying a potential interplay and an increased risk of cervical cancer.

158 Exclusion Criteria . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 29, 2022. 181 Specimen Collection . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 29, 2022. ; https://doi.org/10.1101/2022.06.28.22277026 doi: medRxiv preprint 182 Kavatkar et al. previously described a method for collecting cervical smears, which was used in 183 this study [16]. Following sterile speculum dilatation of the vaginal wall, a cytobrush was 184 introduced into the endocervical canal, turned clockwise, extracted, and placed in fixative. The 185 mixture was allowed to sit for 30 minutes before being labeled [17]. It was then decanted and 186 diluted with cellular solution after being placed into a spin tube and centrifuged at 1500rpm for 187 60 seconds. A 50ul portion of the diluted liquid was utilized to make a smear with a brush, while 188 the rest was kept in the refrigerator for molecular analysis. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 29, 2022. ; https://doi.org/10.1101/2022.06.28.22277026 doi: medRxiv preprint 278 dNTP, 10 pM of each primer, and 2 units of AmpliTaq Gold polymerase (Perkin-Elmer). PCR 279 reactions were denatured at 94°C for 30 seconds, annealed at 55°C for 30 seconds, and extended 280 at 72°C for 30 seconds. Each PCR reaction was followed by a 7-minute extension at 72°C after a 281 5-minute denaturation at 95°C. Depending on the sample DNA, the total number of PCR 282 amplification cycles ranged from 35 to 40. The size of the P53 gene amplification products size 283 were determined using a gel electrophoresis equipment to identify electrophoresis bands. 300 abnormal cytology (dysplasia) was higher than in the normal group. Aside from that, multiple . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 29, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 29, 2022. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 451 Although HPV 16 has been widely reported as the most preponderant genotype, however, 452 attributable to geographical variation, some studies report that HPV16 may not be the most 453 common HPV genotype in some settings. Similarly, different HPV-genotypes have different . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted June 29, 2022. ; https://doi.org/10.1101/2022.06.28.22277026 doi: medRxiv preprint 500 inactivation. On the contrary, this report also indicated that non-HPV-associated mild cervical 501 dysplasia was still a striking figure, 10.7 % (table 2). In addition, both HGSIL and LGSIL do not 502 necessary result in cancer if treatment is instituted aggressively. However, in the aftermath of 503 cervical cancer development, our findings indicated that the idea that hrHPV causes about 99.7% 504 of cancer as repeatedly reported [3,55] or that p53 is exclusively involved in the molecular 505 mechanism requires further investigation. As a result, the stakeholders should be aware of the 506 possibility of a surge of millions of non-HPV-associated cervical cancer cases that might not 507 benefit from vaccines, even though the current vaccination strategies are thought to eradicate 508 cervical cancer in the near future. 509 510 CONCLUSION 511 The p53 mutation and hrHPV infections were thought to be independent risk factors and 512 determinants of cervical cancer development. Our findings, however, showed that the p53 513 mutation coexists in host tissue infected with multiple hrHPV genotypes. This suggests that 514 multiple hrHPV infections and p53 susceptibility may interplay in a way that increases the risk 515 of cervical cancer. However, in a single hrHPV genotype, p53 gene mutation was independent of 516 HPV-associated cervical architectural abnormalities, though other mechanistic drivers attributed 517 to p53 dysfunction by E6 and E7 remained plausible. Furthermore, non-HPV-associated cervical 518 dysplasia was found in 10.7% of the participants in the current study while 99.7% of HPV-519 induced cervical cancer has been repeatedly reported in the literature. Our findings also implied 520 that the PCR employing HPV DNA test is more sensitive than the Pap's smear in detecting 521 hrHPV at an early stage, even before cervical dysplasia develops. As a result, the HPV DNA test 522 should be considered a baseline for early detection. Meanwhile, HPV infection is 523 largely implicated in the pathogenesis of cervical cancer prompting the development of HPV . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 29, 2022.  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 29, 2022. ; https://doi.org/10.1101/2022.06.28.22277026 doi: medRxiv preprint https://doi.org/10.1016/j.foar.2013.11.006.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 29, 2022. ; https://doi.org/10.1101/2022.06.28.22277026 doi: medRxiv preprint 10.1186/1471-2105-7-63.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 29, 2022. ; https://doi.org/10.1101/2022.06.28.22277026 doi: medRxiv preprint